### 12576 Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices

**CONSUMER PRODUCT SAFETY COMMISSION** 

**Sunshine Act Meetings**

**TIME AND DATE :**  Wednesday, March 7, 2012, 10 a.m.–11 a.m.

**PLACE :**  Hearing Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, Maryland.

**STATUS :**  Commission Meeting—Open to the Public.

**MATTERS TO BE CONSIDERED :**  Decisional Matter: Fiscal Year 2012 Operating Plan.

A live webcast of the Meeting can be viewed at www.cpsc.gov/webcast

. **TIME AND DATE :**  Wednesday, March 7, 2012; 11 a.m.—12 p.m.

**PLACE :**  Hearing Room 420, Bethesda Towers, 4330 East West Highway, Bethesda, Maryland.

**STATUS :**  Closed to the Public.

**MATTER TO BE CONSIDERED :**  Compliance Status Report: The Commission staff will brief the Commission on the status of compliance matters.

For a recorded message containing the latest agenda information, call (301)
504–7948.

**CONTACT PERSON FOR MORE INFORMATION :**  Todd A. Stevenson, Office of the Secretary, U.S. Consumer Product Safety Commission, 4330 East West Highway, Bethesda, MD 20814, (301)
504–7923.

Dated: February 28, 2012. Todd A. Stevenson, Secretary. [FR Doc. 2012–5137 Filed 2–28–12; 2:00 pm]

**BILLING CODE 6355–01–P**

**DEPARTMENT OF DEFENSE**

**Office of the Secretary**

**Veterans’ Advisory Board on Dose Reconstruction; Meeting** 

**AGENCY :**  Defense Threat Reduction Agency, DoD.

**ACTION :**  Advisory Board Meeting Notice.

**SUMMARY :**  Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended), the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), the Defense Threat Reduction Agency (DTRA), and the Department of Veterans Affairs (VA) announce the following advisory board meeting of the Veterans’ Advisory Board on Dose Reconstruction (VBDR).

**DATES :**  Friday, March 23, 2012, from 8 a.m. to 12 p.m. and from 1 p.m. to 6 p.m. and Saturday, March 24, 2012, from 9 a.m. to 12 p.m. The public is invited to attend. A public comment session is scheduled from 4 p.m. to 5 p.m. on Friday and from 9:30 a.m. to 10:20 a.m. on Saturday.

**ADDRESSES :**  Embassy Suites Riverwalk Hotel, E. Houston Street, San Antonio, TX 78205.

**FOR FURTHER INFORMATION CONTACT :**  The Veterans’ Advisory Board on Dose Reconstruction Toll Free at 1–866–657– VBDR (8237). Additional information may be found at http://vbdr.org.

**SUPPLEMENTARY INFORMATION :** 

Purpose of Meeting: To obtain, review, and evaluate information related to the Board’s mission to provide guidance and review of the dose reconstruction and claims compensation programs for veterans of U.S.-sponsored atmospheric nuclear weapons tests from 1945–1962; veterans of the 1945–1946 occupation of Hiroshima and Nagasaki, Japan; and veterans who were prisoners of war in those regions at the conclusion of World War II. In addition, the advisory board will assist the VA and DTRA in communicating with the veterans. The meeting will also include public presentations regarding dose reconstruction efforts related to the Fukushima incident in Japan and the McMurdo Station in Antarctica.

Meeting Agenda: The meeting will open on Friday morning with a Call to Order from the Designated Federal Official. Dr. Charles Roadman, the VBDR Chairman will make opening remarks and will introduce the members of the Board. After introductions, the remainder of the morning will include the following briefings: ‘‘Review of Atomic Veterans Epidemiology Study’’ by Dr. John Boice; ‘‘Review of Atomic Veterans Demographic Study’’ by Dr. John Lathrop, ‘‘Review of the Navy’s PM–3A (McMurdo Sound Nuclear Reactor) Dose Reconstruction Effort’’ by LCDR Greg Fairchild, USN; ‘‘Review of the DoD Population of Interest Dose Reconstruction from the Fukushima incident in Japan’’ by Dr. Gerald Falo, Dr. Steven Rademacher, and CDR James Cassata, USN, and an ‘‘Update on the Nuclear Test Personnel Review (NTPR) Dose Reconstruction Program’’, by Dr. Paul Blake. The afternoon session will include additional briefings: ‘‘Update on the VA Radiation Claims Compensation Program for Veterans’’, by Mr. Brad Flohr, ‘‘Presentation on the VA/DTRA/ VBDR Atomic Veterans Communications Plan’’ by Mr. Jim Benson, VA, Mr. Richard Cole, DTRA and Mr. Kenneth Groves and ‘‘Overview of the VA’s Office of Public Health’’ by Dr. Paul Ciminera. Next, the four active subcommittees established during the inaugural VBDR session will report on their activities since March 2011. These subcommittees consist of the following: Subcommittee on DTRA Dose Reconstruction Procedures; the Subcommittee on VA Claims Adjudication Procedures; the Subcommittee on Quality Management and VA Process Integration with DTRA Nuclear Test Personnel Review Program; and the Subcommittee on Communication and Outreach. The afternoon session also includes a one hour open public comment session. The remainder of the Friday afternoon meeting will be devoted to an overview discussion on the VBDR activities. The meeting will reconvene on Saturday morning with an introduction to the Special Session by the VBDR Chairman, Dr. Charles Roadman. The morning session includes an open public comment period and opportunities for discussion with VA and DTRA NTPR representatives. The Designated Federal Official will close the meeting at 12 p.m.

Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited by the size of the meeting room. All persons must sign in legibly at the registration desk.

Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140(c), interested persons may submit a written statement for consideration by the Veterans’ Advisory Board on Dose Reconstruction. Written statementsshould be no longer than two typewritten pages and must address the following: the issue, discussion, and recommended course of action for the VBDR. Supporting documentation may also be included as needed to establish the appropriate historical context and to provide any necessary background information.

Individuals submitting a written statement may submit their statement to the Board at 801 N. Quincy Street, Suite 700, Arlington, VA 22203, at any time. However, if a written statement is not received at least 10 calendar days prior to the meeting, which is the subject of this notice, then it may not be provided to or considered by the Veterans’ Advisory Board on Dose Reconstruction until its next open meeting.

The Chairperson will review all timely submissions with the Designated Federal Officer, and ensure they are provided to members of the Veterans’ Advisory Board on Dose Reconstruction before the meeting that is the subject of this notice. After reviewing the written comments, the Chairperson and the Designated Federal Officer may choose